Academic literature on the topic 'Ready-to-use supplementary food (RUSF)'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Ready-to-use supplementary food (RUSF).'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Ready-to-use supplementary food (RUSF)"
1
Sigh, Sanne, Nanna Roos, Daream Sok, Bindi Borg, Chhoun Chamnan, Arnaud Laillou, Marjoleine A. Dijkhuizen, and Frank T. Wieringa. "Development and Acceptability of Locally Made Fish-Based, Ready-to-Use Products for the Prevention and Treatment of Malnutrition in Cambodia." Food and Nutrition Bulletin 39, no. 3 (August 9, 2018): 420–34. http://dx.doi.org/10.1177/0379572118788266.
Full textAbstract:
Background: Cambodia has a high prevalence of moderate acute malnutrition and severe acute malnutrition (SAM). The SAM treatment requires ready-to-use therapeutic foods (RUTFs), whereas ready-to-use supplementary foods (RUSFs) are used for prevention of acute malnutrition. Three locally produced fish-based products were developed: an RUTF paste (NumTrey-Paste) for treatment and 2 wafer versions, one for prevention (NumTrey-RUSF) and one for treatment (NumTrey-RUTF). Objective: To assess the acceptability of NumTrey-Paste and NumTrey-RUSF in comparison to a standard biscuit product (BP-100) used for the treatment of SAM. Methods: Acceptability of NumTrey-RUSF and NumTrey-Paste was tested in a nonblinded crossover taste trial among children (n = 52), aged ≥ 6 months to 18 years, and their caregivers. Eight organoleptic qualities were assessed on a 5-point hedonic scale, as well as a ranking test. A score of 1 to 3 was categorized as acceptable. The acceptability of NumTrey-RUTF was assessed using the caregivers’ perception during an SAM treatment intervention. Results: Taste trial: The proportion of children categorizing products as overall acceptable was lowest for NumTrey-Paste compared to for BP-100 and NumTrey-RUSF (21% vs 43% [BP-100] and 36% [NumTrey-RUSF]). No difference was found in the proportion of children who ranked BP-100 or NumTrey-RUSF as “liked most” ( P > .05). Acceptability of NumTrey-RUSF ranked highest in appearance and taste (caregiver), whereas acceptability of NumTrey-Paste was ranked lowest in appearance and smell among the products. Intervention trial: The acceptability of NumTrey-RUTF increased from 72% to 86%. Conclusions: The overall acceptability was ranked lowest for a pure paste product. However, filling the paste into a wafer made the product more acceptable.
2
Fetriyuna, Fetriyuna, Ratna Chrismiari Purwestri, May Susandy, Realm Köhler, Ignasius Radix A. P. Jati, Nia Novita Wirawan, and Hans-Konrad Biesalski. "Composite Flour from Indonesian Local Food Resources to Develop Cereal/Tuber Nut/Bean-Based Ready-to-Use Supplementary Foods for Prevention and Rehabilitation of Moderate Acute Malnutrition in Children." Foods 10, no. 12 (December 5, 2021): 3013. http://dx.doi.org/10.3390/foods10123013.
Full textAbstract:
Undernourishment is a threat to human health. The prevalence of undernourishment remains alarming, especially among children under five years old in many countries, including Indonesia. Nowadays, the handling of undernourishment has shifted to treatment outside the hospital, utilizing local nutrient-rich foods. At the national level, the utilization of local food resources is a part of the promotion of dietary diversification and the bioeconomy. Ready-to-use supplementary food (RUSF) refers to supplementary foods aimed at improving the nutrition of moderate acute malnutrition (MAM) children under five years old. RUSF biscuit recipes were made using local food resources available in Banten province, Indonesia. To optimize the nutritional profile of the developed RUSF, taro/talas banten were mixed with ground-nut/peanut (Arachis hypogaea L.) and mungbean (Vigna radiata) as protein and lipid sources and red rice (Oryza longistaminata) and maize (Zea mays) as carbohydrate sources, and enriched by the local banana Nangka (Musa textilia). Two formulations were selected for the pilot testing, namely the taro-peanut and taro-peanut/mungbean RUSF biscuits, made from taro Banten, cereal, peanut and/or mungbean, and local banana. The RUSF biscuit showed promising results, presenting a high level of acceptance and a macronutrient composition that meets the standards for MAM children. However, the RUSF biscuits should be fortified with micronutrient premix to fulfill the dietary requirement for the MAM children. The results of this study provide further development opportunities.
3
Stobaugh, Heather. "Maximizing Recovery and Growth When Treating Moderate Acute Malnutrition with Whey-Containing Supplements." Food and Nutrition Bulletin 39, no. 2_suppl (September 2018): S30—S34. http://dx.doi.org/10.1177/0379572118774492.
Full textAbstract:
Background: Much debate exists about the utility of dairy ingredients in the supplementary foods used to treat childhood moderate acute malnutrition (MAM). Objective: To review the evidence regarding the effectiveness of dairy-containing supplements, particularly specially formulated foods containing whey permeate and whey protein concentrate, in treating children with MAM. Methods: A summary of a conference presentation regarding an overview of current evidence behind the use of whey in supplementary foods, including results of a randomized double-blinded clinical effectiveness trial involving 2259 Malawian children treated for MAM using either a soy ready-to-use supplementary food (RUSF) or a novel whey RUSF treatment. Results: While the majority of the evidence base only suggests potential benefits of including whey in supplementary foods to treat MAM, a recent study specifically demonstrates that a whey RUSF produced superior recovery and growth outcomes in treating children with MAM when compared with a soy RUSF. Conclusions: The use of whey ingredients has been shown to improve outcomes in the treatment of MAM; however, further research is needed to identify the ideal amount and type of dairy protein required to produce the best outcomes for the lowest cost.
4
Das, Jai K., Rehana A. Salam, Marwah Saeed, Faheem Ali Kazmi, and Zulfiqar A. Bhutta. "Effectiveness of Interventions for Managing Acute Malnutrition in Children under Five Years of Age in Low-Income and Middle-Income Countries: A Systematic Review and Meta-Analysis." Nutrients 12, no. 1 (January 1, 2020): 116. http://dx.doi.org/10.3390/nu12010116.
Full textAbstract:
Childhood malnutrition is a major public health concern, as it is associated with significant short- and long-term morbidity and mortality. The objective of this review was to comprehensively review the evidence for the management of severe acute malnutrition (SAM) and moderate acute malnutrition (MAM) according to the current World Health Organization (WHO) protocol using facility- and community-based approaches, as well as the effectiveness of ready-to-use therapeutic food (RUTF), ready-to-use supplementary food (RUSF), prophylactic antibiotic use, and vitamin A supplementation. We searched relevant electronic databases until 11 February 2019, and performed a meta-analysis. This review summarizes findings from a total of 42 studies (48 papers), including 35,017 children. Limited data show some benefit of integrated community-based screening, identification, and management of SAM and MAM on improving recovery rate. Facility-based screening and management of uncomplicated SAM has no effect on recovery and mortality, while the effect of therapeutic milk F100 for SAM is comparable to RUTF for weight gain and mortality. Local food and whey RUSF are comparable to standard RUSF for recovery rate and weight gain in MAM, while standard RUSF has additional benefits to CSB. Prophylactic antibiotic administration in uncomplicated SAM improves recovery rate and probably improves weight gain and reduces mortality. Limited data suggest that high-dose vitamin A supplementation is comparable with low-dose vitamin A supplementation for weight gain and mortality among children with SAM.
5
Ntsama, Patricia M., Julie Judith T. Tsafack, Gabriel Nama Medoua, and Carl M. F. Mbofung. "Preparation of Ready to Use Supplementary Food for Treating Moderate Acute Malnutrition in Children Aged 6 to 59 Months." IRA-International Journal of Applied Sciences (ISSN 2455-4499) 14, no. 3 (May 27, 2020): 22. http://dx.doi.org/10.21013/jas.v14.n3.p1.
Full textAbstract:
<p>Children with moderate malnutrition have a high risk of mortality and MAM is associated with a high number of nutrition-related deaths. If some of these children suffering from MAM do not receive adequate support, they may progress towards severe acute malnutrition (SAM), which is a life-threatening condition. Therefore, the management of MAM should be a public health priority<strong></strong></p><p>A well-balanced diet was prepared based on the recommendation of WHO for the treatment of moderate acute malnourished children aged 6 -59 months. According to the formulae, nine products of RUSF were prepared using cereals, legumes, seeds, oil, sugar, and vitamin and mineral premix. Three products of RUSF MSPe, PBPe, and ISPe were found to be better among the nine products by the mothers after sensory evaluation.</p><p>Based on sensory evaluation in children, RUSF MSPe was found to be the best among the three products. The product was analyzed for proximate composition, mineral, vitamin, digestibility of protein. The protein, fat, carbohydrate, dietary fiber, total ash, vitamin C, Vitamin A, iron, calcium and zinc of 100 g of the product were found to be 15.9g, 33.7g, 44.3g, 6.6g, 2.2g, 54.6 mg, 855 µg, 14.1 mg, 66.6 g and 12.4 µg respectively. The diet can supply 544.5 Kcal/100 g. The energy contributed by the protein, fat, and carbohydrate was found to be 11.68%, 55.7%, and 32.62% of total Kcals respectively. The protein digestibility adjusted to the chemical index PDCASS was 0.95.</p>Hence, the prepared RUSF is in accordance with the specification given by WHO which could be effective in the treatment of moderate acute malnourished children after the clinical trial.
6
Medoua, Gabriel Nama, Patricia M. Ntsama, Anne Christine A. Ndzana, Véronique J. Essa’a, Julie Judith T. Tsafack, and Henriette T. Dimodi. "Recovery rate of children with moderate acute malnutrition treated with ready-to-use supplementary food (RUSF) or improved corn–soya blend (CSB+): a randomized controlled trial." Public Health Nutrition 19, no. 2 (May 5, 2015): 363–70. http://dx.doi.org/10.1017/s1368980015001238.
Full textAbstract:
AbstractObjectiveTo compare an improved corn–soya blend (CSB+) with a ready-to-use supplementary food (RUSF) to test the hypothesis that satisfactory recovery rate will be achieved with CSB+ or RUSF when these foods provide 50 % of the child’s energy requirement, the 50 % remaining coming from usual diet.DesignA comparative efficacy trial study was conducted with moderately wasted children, using a controlled randomized design, with parallel assignment for RUSF or CSB+. Every child received a daily ration of 167 kJ (40 kcal)/kg body weight during 56 d with a follow-up performed every 14 d. Every caregiver received nutrition counselling at enrolment and at each follow-up visit.SettingHealth districts of Mvog-Beti and Evodoula in the Centre region of Cameroon.SubjectsEight hundred and thirty-three children aged 6–59 months were screened and eighty-one malnourished children (weight-for-height Z-score between −3 and −2) aged 25–59 months were selected.ResultsOf children treated with CSB+ and RUSF, 73 % (95 % CI 59 %, 87 %) and 85 % (95 % CI 73 %, 97 %), respectively, recovered from moderate acute malnutrition, with no significant difference between groups. The mean duration of treatment required to achieve recovery was 44 d in the RUSF group and 51 d in the CSB+ group (log-rank test, P=0·0048).ConclusionsThere was no significant difference in recovery rate between the groups. Both CSB+ and RUSF were relatively successful for the treatment of moderate acute malnutrition in children. Despite the relatively low ration size provided, the recovery rates observed for both groups were comparable to or higher than those reported in previous studies, a probable effect of nutrition education.
7
Steenkamp, Liana, Ronette Lategan, and Jacques Raubenheimer. "The impact of Ready-to-Use Supplementary Food (RUSF) in targeted supplementation of children with moderate acute malnutrition (MAM) in South Africa." South African Family Practice 57, no. 5 (September 1, 2015): 4. http://dx.doi.org/10.4102/safp.v57i5.4192.
Full textAbstract:
Objective: To describe catch-up growth in children with moderate acute malnutrition (MAM) on targeted supplementation using Ready-to-Use Supplementary Food (RUSF). Methods: An impact study was done to determine anthropometric changes in children aged 12–60 months who received RUSF (175 kcal/kg/day) for six weeks, managed as outpatients and followed up for 12 weeks until a final assessment. Results: Default rates were high, with 30% of children returning to the primary healthcare facility for follow-up only once or twice. Despite significant improvement in height-for-age Z-score (HAZ), weight-for-age Z-score (WAZ), weight-for-height Z-score (WHZ) and mid-upper arm circumference (MUAC), 70.5% of the sample remained in the same malnutrition classification and only 26% recovered. The growth velocity of children with a lower initial WHZ was significantly higher (r = –0.15, p 0.05) than those with less wasting, but only 20% grew at a rate to achieve catch-up growth. The mean growth velocity decreased as the intervention period continued. Conclusion: All median anthropometric indicators improved with RUSF supplementation. However, catch-up growth or recovery occurred in only 20–25% of children included in the study. These findings create questions about the value of supplementation in the absence of blanket food distribution or other interventions to address food security.
8
Schlossman, Nina, Carrie Brown, Payal Batra, Augusto Braima de Sa, Ionela Balan, Adrian Balan, Madeleine G. Gamache, et al. "A Randomized Controlled Trial of Two Ready-to-Use Supplementary Foods Demonstrates Benefit of the Higher Dairy Supplement for Reduced Wasting in Mothers, and Differential Impact in Infants and Children Associated With Maternal Supplement Response." Food and Nutrition Bulletin 38, no. 3 (April 4, 2017): 275–90. http://dx.doi.org/10.1177/0379572117700754.
Full textAbstract:
Background: There is no consensus over best approaches to reliably prevent malnutrition in rural communities in low-income countries. Objective: We compared the effectiveness of 2 lipid-based ready-to-use supplementary foods (RUSFs) differing in dairy protein content to improve the nutritional status of mothers and at-risk infants and young children in rural Guinea-Bissau. Methods: A 3-month cluster-randomized controlled pilot trial of 2 RUSFs was conducted with 692 mothers and 580 mildly or moderately malnourished infants (6-23 months) and children (24-59 months) from 13 villages. The RUSFs contained either 478 (mothers, children) or 239 kcal/d (infants) with 15% or 33% of protein from dairy and were distributed at community health centers 5 d/wk. Controls were wait-listed to receive RUSF. Primary outcomes were mid-upper arm circumference (MUAC) in mothers, and weight-for-age and height-for-age z-scores (WAZ and HAZ) in infants and children. Results: There was a significant effect of the RUSF-33% on MUAC in mothers ( P = .03). The WAZ and HAZ increased substantially, by ≈1 z-score, in infants and children ( P < .01) independent of group randomization. In children, but not infants, baseline WAZ and change in maternal MUAC were associated with change in WAZ (β = .07, P = .02). Conclusion: Ready-to-use supplementary foods with higher dairy protein content had a significant benefit in village mothers, supporting a comparable recent finding in preschool children. In addition, supplementation of children <2 years resulted in improved growth independent of family nutritional status, whereas success in older children was associated with change in maternal nutrition, suggesting the need for community-level education about preventing malnutrition in older, as well as younger, children.
9
Cox, Sharon E., Julie Makani, Gurishaeli Walter, Selemani Mtunguja, Beatrice A. Kamala, Elizabeth Ellins, Charles RJ Newton, Fenella J. Kirkham, Andrew M. Prentice, and Julian P. Halcox. "Ready-to-Use Supplementary Food Supplements Improve Endothelial Function, Hemoglobin and Growth in Tanzanian Children with Sickle Cell Anaemia: The Vascular Function Intervention Study (V-FIT), a Random Order Crossover Trial." Blood 124, no. 21 (December 6, 2014): 4087. http://dx.doi.org/10.1182/blood.v124.21.4087.4087.
Full textAbstract:
Abstract Introduction: Endothelial function is impaired in sickle cell anemia (SCA) and may be prognostic of severity of pathophysiology underlying many complications. Poor nutritional status is documented in SCA in all income settings, yet no strategies exist to improve nutrition. Poor nutritional status and hemoglobin predict death and hospitalization in Tanzanian SCA patients (Cox, et al. Haematologica 96, 2011, Makani et al. PloSONE 6, 2011). The objectives are to determine the combined effect of two ready-to-use-supplementary food (RUSF) interventions on the primary endpoints of endothelial function, assessed by flow mediated dilatation (FMD), growth and body composition and hemoglobin (secondary endpoint). Methods: Tanzanian children (N=119) (HbSS) aged 8-11.9 years were enrolled in V-FIT (ISRCTN74331412/NCT01718054) in Aug to Nov 2012. Children received in random order a daily RUSF providing 500 kcal, 1 RDA of vitamins and minerals & 1mg folate (Nutriset, France), plus weekly anti-malarial prophylactic chloroquine syrup (150/225mg base) (Wallace manufacturing chemicals, UK), or a vascular-RUSF (RUSFv) fortified with arginine and citrulline (average 0.2g/kg/d & 0.1g/kg/d) plus daily chloroquine syrup (3mg base/kg/d). Patients and investigators were blind to the different interventions. Each intervention was received for 4 months with 4 month washout periods on either side (Figure 1A). Clinic visits were conducted at baseline and at the end of each intervention/washout period when endothelium-dependent and -independent vasodilatation were assessed (Donald et al. JACC 51, 2008), plus height, weight and body composition by impedance (Tanita BC418). Random effects models were used, adjusting for repeated measures within individuals. In multivariable analyses models were a priori adjusted for gender. Possible temporal effects were modelled via Fourier transformation of visit dates and included in models for growth and hemoglobin. Effects of the interventions on FMDmax were adjusted for arterial diameter before vasodilation induction, which was negatively correlated with FMDmax and for magnitude of reactive hyperaemia during induction of vasodilation, which was not correlated with FMDmax. Results: 115/119 (60% male; mean age at enrolment 10.0, 95% CI 9.8 – 10.2 years) enrolled patients completed the trial and all clinic visits. Endpoints at baseline and the adjusted and unadjusted effects of the interventions are shown in Table 1. FMDmax, baseline brachial diameter, absolute change in blood flow velocity during reactive hyperemia, hemoglobin, height velocity, weight and lean mass gain all increased on the RUSF (Fig 1B-F). Discussion: We demonstrate that providing extra protein, energy and micronutrients improves hemoglobin, vascular endothelial function and growth. It is possible that the effects observed are limited to the RUSFv, and/or from unadjusted for temporal effects. Unblinded analysis of the effect of RUSFv vs. RUSF on these endpoints, plasma amino acids and arginase are planned. Currently the only intervention for children with SCA is hydroxyurea, which although it improves hemoglobin and reduces hemolysis, does not appear to affect growth while its effect on vascular physiology is unknown (Wang et al. J Pediatr 140, 2002). In addition to specific nutrients, general improvement in nutrition may result in improvement in important intermediate endpoints in SCA. Future research should investigate effects of nutritional supplementation on clinical endpoints. Abstract 4087. Table 1. Endpoints at enrolment and combined effect of RUSF interventions. Baseline N=119 RUSF coefficient [95% CI] P-value Adjusted RUSF coefficient [95% CI] Adjusted P-value Endothelial function, mean [SD] FMDmax % 7.66 [3.37] 0.66 [0.15 – 1.17] 0.011 0.98 [0.42 – 1.54] 0.001 Baseline brachial diameter, mm 2.61 [0.35] 0.05 [0.03 – 0.09] <0.001 - - Reactive hyperemia absolute, m/s 0.69 [0.22] 0.034 [0.004 – 0.065] 0.026 - - Anemia, mean [95% CI] Hemoglobin, g/dl 7.5 [7.3 – 7.7] 0.29 [0.20 – 0.37] <0.001 0.34 [0.22 – 0.46] <0.001 Anthropometry, mean [95% CI] Height cm 126.5 [125.2 – 127.8] - - - - Linear growth velocity, cm/yr - 0.46 [0.08 – 0.83] 0.018 0.51 [0.01 – 1.02] 0.053 Weight, kg 22.8 [22.1 – 23.5] - - - - Weight gain, kg/yr - 1.37 [0.83 – 1.91] <0.001 1.98 [1.25 – 2.73] <0.001 Whole body fat free mass, kg 18.6 [18.1 – 19.1] - - - - Fat free mass gain, kg/yr - 0.89 [0.48 – 1.30] <0.001 0.93 [0.36 – 1.50] 0.001 Disclosures No relevant conflicts of interest to declare.
10
Sastrawan, S., M. Menap, L. Sulaiman, and H. Hendrayani. "Development of home-based ready-to-use supplementary food (RUSF-HB) to overcome nutrition-related problems among children under five during the covid-19 pandemic." IOP Conference Series: Earth and Environmental Science 883, no. 1 (October 1, 2021): 012074. http://dx.doi.org/10.1088/1755-1315/883/1/012074.
Full textAbstract:
Abstract The most direct causes of malnutrition are food consumption and infection. Yet the prolonged Covid-19 pandemic has limited low-income families’ ability to fulfil the need for nutrition consumption, particularly for children under five. Responding to this situation, we sought to develop home-based ready-to-use supplementary foods (RUSF-HB) from local ingredients that are energy-protein-dense, affordable, simple and easy to produce at home. We created three milk-free formulas (MFFs) and six standard formulas (STFs). Three cheap and abundant local foods: soybeans, cowpeas, and mung beans were combined with rice flour, refined sugar, and coconut oil. A cross-over study design was used to assess food organoleptic, which showed that the products were comparable in several sensory aspects except for the odour and the taste. Soybeans-based formulas contain slightly more energy and protein compared to mung beans or cowpeas-based ones. However, the mung beans-based formulas were more favourable to caregivers and children, particularly their taste and smell. The products contain slightly less energy than the recommended ones but high enough to supply macronutrient for those in need on a regular basis. The caregivers considered the total price for the products was affordable, and the formula was easy to follow.
Dissertations / Theses on the topic "Ready-to-use supplementary food (RUSF)"
1
Borg, Bindi. "Acceptability and Effectiveness of a Locally-Produced Ready-to-Use Supplementary Food (RUSF) for Prevention of Undernutrition in Children Under Two Years in Cambodia." Thesis, The University of Sydney, 2019. https://hdl.handle.net/2123/21674.
Full textAbstract:
We tested a locally-produced, fish-based multiple micronutrient fortified lipid-based nutrient supplement (LNS) snack as a ready-to-use supplementary food (RUSF) to prevent undernutrition in Cambodian children under 2 years. Our first trial assessed the RUSF’s acceptability as a snack or mixed with borbor (white rice porridge) compared to Corn-Soy Blend Plus Plus (CSB++), and micronutrient powders (MNP) with borbor. The second assessed its effectiveness in reducing growth faltering compared to CSB++, MNP, and an unsupplemented control group. The acceptability trial with 92 children aged 9-23 months assessed children’s consumption, caregivers’ assessment of children’s preferences and caregivers’ ranking of foods. The cluster-randomised controlled effectiveness trial allocated 485 healthy children aged 6-17 months to RUSF, CSB++, MNP or control groups for 6 months. Outcomes were weight-for-age (WAZ), height-for-age (HAZ), weight- for-height (WHZ), and mid-upper arm circumference (MUAC). In acceptability testing, odds of children consuming >50% were greatest for MNP-borbor versus RUSF snack. Caregivers reported that children had the highest preference for MNP-borbor, then for the RUSF snack. Caregivers ranked the RUSF snack highest. In the effectiveness trial, growth faltered from baseline to endline, with no significant differences between interventions and control. In unadjusted analysis, the RUSF group had greater increases in MUAC than CSB++ or the control. For other outcomes, the RUSF did not differ significantly from the control, which had decreased WAZ and HAZ and no significant change in WHZ. In adjusted analysis, high consumers of RUSF had increased MUAC compared to control, but no statistically significant differences to CSB++ or MNP. Low consumers of RUSF had increased WAZ, WHZ and MUAC. Our trials demonstrated that the novel RUSF is acceptable and slowed, but did not prevent, growth faltering.
2
Maharaj, Kirasha. "Supplementary feeding of South African underweight children between 1 and 10 years of age with ready-to-use food to promote weight gain." Thesis, 2012. http://hdl.handle.net/10413/10134.
Full textAbstract:
The aim of this study was to investigate whether Sibusiso, a Ready Food Supplement (SRFS), developed by the Gift of the Givers Foundation was able to promote weight gain among underweight children between 1 and 10 years of age. The study also aimed to train CAST community workers on how to assess and identify underweight children and to determine the number of underweight children aged 1-10 years who were currently on the CAST food aid program in Cato Manor and Chesterville in Durban, Kwa Zulu-Natal. This non-randomised intervention study was carried out on a total of 19 out of 20 subjects that initially qualified for inclusion into the study. A monitoring tool was used to collect data on anthropometrical measurements, symptoms experienced, disease conditions identified, level of appetite, meal consumption and energy for each subject for a period of three months. Study subjects were from families living in Cato Manor and Chesterville in Durban, Kwa Zulu-Natal, who were part of a food aid programme run by non-governmental organisation Church Alliance of Social Transformation (CAST). SRFS was compared to Recommended Energy Allowances (REA) and Recommended Daily Allowances (RDA) to determine the amount of energy and macronutrients that SRFS provided to subjects in their different age groups. The predominant health conditions and symptoms experienced by the subjects were assessed. General improvement in appetite, meal consumption and energy levels among subjects were monitored during the supplementation period
Out of 19 subjects who were supplemented with SRFS over the three month period, it was established that more children from Chesterville than Cato Manor were part of the CAST food parcel programme. SRFS was not able to meet 100% of the RDA and REA for subjects in their different age groups. However, SRFS was able to promote weight among subjects as
50% of subjects were able to achieve normal weight-for-age growth by the third month of supplementation. Human Immunodeficiency Virus (HIV) infection was the predominant disease condition experienced among subjects. A steady decline in the frequency of infection symptoms experienced among subjects was observed. Appetite, meal consumption and energy levels among subjects increased during the three moth supplementation period.
In conclusion, SRFS was successful in promoting weight gain among underweight children and was able to improve the overall wellbeing of subjects by alleviating the burden of disease conditions and infection symptoms while improving appetite, meal consumption and energy levels. SRFS therefore was beneficially utilised in the CAST food aid programme. SRFS had beneficial effects on the health and nutritional status of the study subjects during the observed period of its use in the CAST food aid programme and its continued use is recommended.Thesis (M.Sc.Diet.)-University of KwaZulu-Natal, Pietermaritzburg, 2012.
3
Ndekha, MacDonald Joseph. "Randomised controlled trial comparing the impact of supplementary feeding with either ready-to-use therapeutic food or corn-soy blend among malnourished anti-retroviral therapy clients in Malawi." Thesis, 2014.
Find full textAbstract:
Thesis (Ph.D.)--University of the Witwatersrand, Faculty of Health Sciences, 2013.Objectives: To investigate the effect of two different food supplements on body mass index (BMI) and fat-free body mass in wasted HIV-infected Malawian adults commencing highly active antiretroviral therapy (ART). Design: Randomised controlled, investigator blinded, clinical trial. Setting: Large, public ART clinic in a referral hospital in Blantyre, Malawi. Participants: 491 adults (>18 years) initiating ART with a body mass index (BMI) <18.5. Interventions: After screening for study-eligibility, consenting new ART registrants were randomised to receive either ready-to-use therapeutic food (RUTF) (n=245), or corn-soy blend (CSB) (n=246) supplements. Main outcome measures: The primary outcomes were changes in BMI and fat-free body mass following completion of an initial 3.5-month of both ART and supplementary feeding, and subsequently after 9.5 months of ART alone once supplementary feeding had stopped. Secondary outcomes were survival, hospitalisations, changes in health-related quality of life (HRQoL) assessment scores at 3.5, 6.5, 9.5 and 12.5 months, improvements from baseline in CD4 count, serum albumin, haemoglobin and HIV RNA viral load at 3.5 months, and adherence to ART. Results: A total of 1,343 new ART registrants during the study period were screened for study eligibility, from which some 511 individuals were study-eligible. Of these, 491 individuals (96%) were enrolled, 245 and 246 in the RUTF and CSB cohorts, respectively, with a mean BMI of 16.5 kg/m2. Following the 3.5-month supplementary feeding, study participants in the RUTF group had a significantly greater increase in BMI (2.1 [SD 1.8]) v 1.6 [SD 1.6] kg/m2, mean difference 0.50, 95% CI 0.10 to 0.80; p<0.01), and fat-free body mass (2.9 [SD 3.2] v 2.2 [SD 3.0] kg, mean difference 0.70, 95% CI 0.20 to 1.20; p< 0.01) compared to participants in the CSB cohort. No significant differences in CD4 count, HIV viral load, HRQoL measurements or ART adherence were noted between the two cohorts. Mortality was high and similar in both cohorts (27% v 26% in the RUTF and CSB cohorts, respectively). Multivariate Cox hazard modelling identified male gender (HR 1.75, 95% CI 1.32 to 2.31), lack of access to cotrimoxazole prophylaxis (CTX) (HR 2.4, 95% CI 1.3 to 4.7), severe wasting (BMI <16.0) at baseline (hazard ratio [HR] 10.3, 95% confidence interval [CI] 1.3 to 79.7), lower lean body mass (% body composition) (HR 10.3, 95% CI 1.2 to 86.8) at baseline and weight gain ≥ 10% of the initial body weight at 1.5-month study follow-up (HR 3.9, 95% CI 1.8 to 8.4), as factors significantly associated with high “early” (3.5-month) mortality. Trial retention rate on completion of the 3.5-month feeding intervention was 162/245 (66.1%) and 174/246 (70.7%) in the RUTF and CSB cohorts, respectively. Both groups continued with ART only thereafter. Nine and half months after the feeding intervention stopped, both cohorts had a similar BMI and fat-free body mass. Additionally, health-related quality of life, ART adherence, hospitalisations and mortality were similar between the two cohorts. Cox hazard modelling identified a lower lean body mass (% body composition) (HR 130, 95% CI 6.3 to 2699), a CD4 count of 50-199 (HR 3.7, 95% CI 1.2 to 11.1) and a CD4 count <50 (HR 11.9, 95% CI 2.1 to 65.2) at 3.5-month follow-up as factors significantly associated with post-supplementary feeding ART mortality. Conclusions: Supplementary feeding with RUTF resulted in a greater increase in BMI and fat-free body mass compared to feeding with CSB while study participants were receiving the food supplements. Although feeding with RUTF can ameliorate an established risk factor for xi mortality in HIV infection- BMI - the benefit is maintained only during the supplementary feeding period, and there was no evidence that this conferred any other benefits to study participants as they continued with ART. Targeted feeding of wasted ART patients for a period longer than 3 months, or pre-ART supplementary feeding of wasted patients to improve their BMI, merits future research.
Conference papers on the topic "Ready-to-use supplementary food (RUSF)"
1
Setiyani, Solikhah Eli, and Fitria Siswi Utami. "Supplementary Food Therapy for the Recovery of Malnourished Children 0-59 Months: A Systematic Review." In The 7th International Conference on Public Health 2020. Masters Program in Public Health, Universitas Sebelas Maret, 2020. http://dx.doi.org/10.26911/the7thicph.03.09.
Full textAbstract:
ABSTRACT Background: Acute malnutrition is the highest cause of death among children under five. This is because children are a group that is vulnerable to health problems, one of which is infection. In this phase there is a very rapid growth and development in children. This problem occurs in part in low- and middle-income countries. This study aimed to review the effect of supplementary food therapy for recovery among malnourished children aged 0-59 months. Subjects and Methods: This was a scoping review using the Arksey and O’Malley framework. The framework used to identify relevant studies is Population, Intervention, Comparison, and Outcome (PICO), with a search strategy using 5 databases, namely PubMed, Science Direct, Proquest, Wiley, and Google Scholar which match the inclusion and exclusion criteria. Results: Supplementary food therapy for recovery of malnourished children 0-59 months could be done with inpatient and outpatient care using Modified Dried Skilled Milk and Coconut Oil (Modisco), Ready to use Therapeutic Food (RUTF), Soy Maize Sorghum RUTF (SMS RUTF), F 75, and F 100. The most widely used recovery supplementary food therapies are Modisco, RUTF, SMS RUTF, F75 and F100. RUTF in Indonesia has not been widely used for the therapy of malnourished children, while for F75 and F100 it has been used as a treatment but not maximally because it tastes bad so it is not liked by children. Conclusion: Several studies have examined the effectiveness of these supplementary foods, apart from being used in the hospital, they can also be given on an outpatient basis with the supervision of related health workers. Keywords: children, malnutrition, therapy, supplementary food Correspondence: Solikhah Eli Setiyani. Universitas Aisyiyah Yogyakarta, Indonesia. Email: elisetiyani01@gmail.com DOI: https://doi.org/10.26911/the7thicph.03.09